Page 36 - BPOM Terbitkan EUA Vaksin Indovac dan Vaksin AWcorna

This momentum is expected to encourage the national pharmaceutical industry to continue to
innovate by producing vaccines using the latest technology that are capable of competing on
the global stage.

"BPOM expresses its appreciation of the COVID-19 Vaccine Evaluator National Committee
Experts Team and immunization experts over their cooperation in allowing this vaccine to be
promptly released to the public," Lukito remarked.

The AWcorna has been registered by PT Etana Biotechnologies Indonesia (PT Etana) and is
being developed through technology transfer and research with Abogen-Yuxi Walvax, China.

The mRNA platform development has involved 250 Indonesian researchers at PT Etana's
production facility in Pulogadung, East Jakarta.